LEADING THE WAY IN ANTI-CANCER DRUG DISCOVERY & DEVELOPMENT
For a full listing of all Taiho studies globally, please click here.
P
Preclinical1
Phase 12
Phase 23
Phase 3S
SubmittedF
Filed|
Compounds
Ind
Code |
Indications
|
Location
|
Phase
|
|---|
P
Preclinical1
Phase 12
Phase 23
Phase 3S
SubmittedF
FiledPLEASE NOTE: all data is current as of December 31, 2018.
* This material contains information regarding investigational agents that, unless otherwise indicated have not been approved for commercial use by any country's Regulatory Authority. In addition, the clinical efficacy and safety for these investigational agents has not been established. There is no guarantee that these compounds will become commercially available or proven safe and effective for any particular therapeutic indication.
